132 related articles for article (PubMed ID: 15136237)
1. Xenobiotic gene polymorphisms and susceptibility to multiple myeloma.
Lincz LF; Kerridge I; Scorgie FE; Bailey M; Enno A; Spencer A
Haematologica; 2004 May; 89(5):628-9. PubMed ID: 15136237
[TBL] [Abstract][Full Text] [Related]
2. Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR.
McKeown-Eyssen G; Baines C; Cole DE; Riley N; Tyndale RF; Marshall L; Jazmaji V
Int J Epidemiol; 2004 Oct; 33(5):971-8. PubMed ID: 15256524
[TBL] [Abstract][Full Text] [Related]
3. Genetic variations in benzene metabolism and susceptibility to multiple myeloma.
Lincz LF; Scorgie FE; Robertson R; Enno A
Leuk Res; 2007 Jun; 31(6):759-63. PubMed ID: 16949155
[TBL] [Abstract][Full Text] [Related]
4. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
5. N-acetyltransferase 2 polymorphisms in patients with Behcet's disease.
Tamer L; Tursen U; Eskandari G; Ates NA; Ercan B; Yildirim H; Atik U
Clin Exp Dermatol; 2005 Jan; 30(1):56-60. PubMed ID: 15663505
[TBL] [Abstract][Full Text] [Related]
6. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
[TBL] [Abstract][Full Text] [Related]
7. Review of studies of selected metabolic polymorphisms and cancer.
d'Errico A; Malats N; Vineis P; Boffetta P
IARC Sci Publ; 1999; (148):323-93. PubMed ID: 10493265
[No Abstract] [Full Text] [Related]
8. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: effects on levels of sister chromatid exchanges and chromosomal aberrations.
Tuimala J; Szekely G; Wikman H; Järventaus H; Hirvonen A; Gundy S; Norppa H
Mutat Res; 2004 Oct; 554(1-2):319-33. PubMed ID: 15450429
[TBL] [Abstract][Full Text] [Related]
9. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study.
Manfredi S; Federici C; Picano E; Botto N; Rizza A; Andreassi MG
Mutat Res; 2007 Aug; 621(1-2):106-12. PubMed ID: 17408703
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia.
D'Alò F; Voso MT; Guidi F; Massini G; Scardocci A; Sica S; Pagano L; Hohaus S; Leone G
Haematologica; 2004 Jun; 89(6):664-70. PubMed ID: 15194533
[TBL] [Abstract][Full Text] [Related]
12. Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk.
Kerridge I; Lincz L; Scorgie F; Hickey D; Granter N; Spencer A
Br J Haematol; 2002 Aug; 118(2):477-81. PubMed ID: 12139735
[TBL] [Abstract][Full Text] [Related]
13. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
14. [Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility].
González A; Ramírez V; Cuenca P; Sierra R
Rev Biol Trop; 2004 Sep; 52(3):591-600. PubMed ID: 17361553
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator.
Anantharaman D; Chaubal PM; Kannan S; Bhisey RA; Mahimkar MB
Carcinogenesis; 2007 Jul; 28(7):1455-62. PubMed ID: 17307803
[TBL] [Abstract][Full Text] [Related]
16. GSTM1 and codon 72 P53 polymorphism in multiple myeloma.
Ortega MM; Honma HN; Zambon L; Lorand-Metze I; Costa FF; De Souza CA; Lima CS
Ann Hematol; 2007 Nov; 86(11):815-9. PubMed ID: 17653713
[TBL] [Abstract][Full Text] [Related]
17. Relation of PON1 and CYP1A1 genetic polymorphisms to clinical findings in a cross-sectional study of a Greek rural population professionally exposed to pesticides.
Tsatsakis AM; Zafiropoulos A; Tzatzarakis MN; Tzanakakis GN; Kafatos A
Toxicol Lett; 2009 Apr; 186(1):66-72. PubMed ID: 19022366
[TBL] [Abstract][Full Text] [Related]
18. Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection.
Joseph T; Chacko P; Wesley R; Jayaprakash PG; James FV; Pillai MR
Gynecol Oncol; 2006 Jun; 101(3):411-7. PubMed ID: 16360200
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer.
Sharma A; Mishra A; Das BC; Sardana S; Sharma JK
Neoplasma; 2006; 53(4):309-15. PubMed ID: 16830058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
